RxDoctor Payments Data

Tawatchai Paisansinsup

Rheumatology · St Louis Park, MNNPI 1881671881

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 25th percentile of 121 rheumatology providers in Minnesota.

See all rheumatology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,044,160
Medicare patients
503
Services billed
50,695

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab122$837,008
Enbrel SureclickEtanercept37$289,012
EnbrelEtanercept33$247,327
Humira(Cf)Adalimumab24$212,398
Cyltezo(Cf) PenAdalimumab-Adbm26$201,299
ActemraTocilizumab12$57,000
MethotrexateMethotrexate Sodium683$20,832
Leflunomide141$15,420
Hydroxychloroquine Sulfate118$5,615
Prednisone360$4,746
Febuxostat13$3,916
Celecoxib32$2,052
Azathioprine26$2,008
Alendronate Sodium147$1,962
Mycophenolate Mofetil14$1,847

Paid to pharmacies, not to this prescriber.

Other rheumatology in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →